Medicinal Products

Ocaliva

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Ocaliva
Active Substance obetikolatna kiselina
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code A05AA04
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o novoj kontraindikaciji lijeka Ocaliva (obetikolatna kiselina) za liječenje primarnog bilijarnog kolangitisa (PBK) u bolesnika s dekompenziranom cirozom jetre ili ranijom epizodom dekompenzacije jetre u anamnezi 09.06.2022 Intercept Pharma International Ltd.
Pismo zdravstvenim radnicima o preporukama za diferencijalno doziranje lijeka Ocaliva (obetikolatna kiselina) 08.02.2018 Intercept Pharma Ltd
Back